4//SEC Filing
STONE HEISZ LESLIE 4
Accession 0001225208-24-001791
CIK 0001099800other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 6:08 PM ET
Size
8.1 KB
Accession
0001225208-24-001791
Insider Transaction Report
Form 4
STONE HEISZ LESLIE
Director
Transactions
- Exercise/Conversion
Director Stock Option (Right to Acquire)
2024-02-08−7,056→ 0 totalExercise: $36.86From: 2017-05-12Exp: 2024-05-11→ Common Stock (7,056 underlying) - Exercise/Conversion
Common Stock
2024-02-08$36.86/sh+7,056$260,107→ 34,036 total - Sale
Common Stock
2024-02-08$86.45/sh−7,056$609,991→ 26,980 total
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001235408
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 6:08 PM ET
- Size
- 8.1 KB